EP0296597A3 - Hexa-cyclic compound - Google Patents

Hexa-cyclic compound Download PDF

Info

Publication number
EP0296597A3
EP0296597A3 EP19880110044 EP88110044A EP0296597A3 EP 0296597 A3 EP0296597 A3 EP 0296597A3 EP 19880110044 EP19880110044 EP 19880110044 EP 88110044 A EP88110044 A EP 88110044A EP 0296597 A3 EP0296597 A3 EP 0296597A3
Authority
EP
European Patent Office
Prior art keywords
compound
hexa
cyclic compound
antitumour
camptothecin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP19880110044
Other languages
German (de)
French (fr)
Other versions
EP0296597A2 (en
EP0296597B1 (en
Inventor
Hiroaki C/O Daiichi Seiyaku Research Tagawa
Masamichi C/O Daiichi Seiyaku Research Sugimori
Hirofumi C/O Daiichi Seiyaku Research Terasawa
Akio C/O Daiichi Seiyaku Research Ejima
Satoru C/O Daiichi Seiyaku Research Ohsuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Yakult Honsha Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Yakult Honsha Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd, Yakult Honsha Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Publication of EP0296597A2 publication Critical patent/EP0296597A2/en
Publication of EP0296597A3 publication Critical patent/EP0296597A3/en
Application granted granted Critical
Publication of EP0296597B1 publication Critical patent/EP0296597B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Luminescent Compositions (AREA)
  • Lubricants (AREA)
  • Fats And Perfumes (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Liquid Crystal Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

A novel hexa-cyclic compound, a derivative of camptothecin, of the general formura:
The compound is prepared from an aminoketone compound and a pyranoindolizine compound through Friedlaender reaction. It has an excellent antitumour activity and a high degree of safety, and can be applied as an antitumour medicine for curing tumors of various kinds.
EP88110044A 1987-06-24 1988-06-23 Hexa-cyclic compound Expired - Lifetime EP0296597B1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP156990/87 1987-06-24
JP15699087 1987-06-24
JP5503/88 1988-01-13
JP550388 1988-01-13

Publications (3)

Publication Number Publication Date
EP0296597A2 EP0296597A2 (en) 1988-12-28
EP0296597A3 true EP0296597A3 (en) 1991-07-31
EP0296597B1 EP0296597B1 (en) 1994-09-21

Family

ID=26339454

Family Applications (1)

Application Number Title Priority Date Filing Date
EP88110044A Expired - Lifetime EP0296597B1 (en) 1987-06-24 1988-06-23 Hexa-cyclic compound

Country Status (13)

Country Link
US (2) US4939255A (en)
EP (1) EP0296597B1 (en)
KR (1) KR960002853B1 (en)
AT (1) ATE111913T1 (en)
AU (1) AU610189B2 (en)
CA (1) CA1304370C (en)
DE (1) DE3851577T2 (en)
DK (1) DK344488A (en)
ES (1) ES2064329T3 (en)
FI (1) FI91872C (en)
IE (1) IE61281B1 (en)
NO (1) NO167738C (en)
PH (1) PH27557A (en)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4939255A (en) * 1987-06-24 1990-07-03 Daiichi Pharmaceutical Co., Ltd. Hexa-cyclic camptothecin derivatives
US5552154A (en) * 1989-11-06 1996-09-03 The Stehlin Foundation For Cancer Research Method for treating cancer with water-insoluble s-camptothecin of the closed lactone ring form and derivatives thereof
JP3008226B2 (en) * 1991-01-16 2000-02-14 第一製薬株式会社 Hexacyclic compounds
US5658920A (en) * 1991-01-16 1997-08-19 Daiichi Pharmaceutical Co., Ltd. Substituted 1H,12H-benz-[DE]pyrano[3',4':6,7] indolizino[1,2-B]quinoline-10,13(9H,15H)-dione compound
US6407115B1 (en) * 1991-01-16 2002-06-18 Daiichi Pharmaceutical Co., Ltd. Hexa-cyclic compound
US6080751A (en) * 1992-01-14 2000-06-27 The Stehlin Foundation For Cancer Research Method for treating pancreatic cancer in humans with water-insoluble S-camptothecin of the closed lactone ring form and derivatives thereof
US5446047A (en) * 1992-07-23 1995-08-29 Sloan-Kettering Institute For Cancer Research Camptothecin analogues
US5391745A (en) * 1992-07-23 1995-02-21 Sloan-Kettering Institute For Cancer Research Methods of preparation of camptothecin analogs
US6504029B1 (en) * 1995-04-10 2003-01-07 Daiichi Pharmaceutical Co., Ltd. Condensed-hexacyclic compounds and a process therefor
US5663177A (en) * 1995-05-31 1997-09-02 Smithkline Beecham Corporation Water soluble camptothecin analogs
US5670500A (en) * 1995-05-31 1997-09-23 Smithkline Beecham Corporation Water soluble camptothecin analogs
EP0835303A4 (en) * 1995-06-07 2000-09-13 Univ Jefferson Anti-fungal agents and methods of identifying and using the same
SG50747A1 (en) * 1995-08-02 1998-07-20 Tanabe Seiyaku Co Comptothecin derivatives
SG104284A1 (en) * 1996-10-30 2004-06-21 Tanabe Seiyaku Co S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof
KR19980076076A (en) * 1997-04-04 1998-11-16 유현식 Expandable resin composition for electric wire
US6046209A (en) * 1997-05-27 2000-04-04 Smithkline Beecham Corporation Water soluble camptothecin analogs
IN189180B (en) * 1997-07-09 2003-01-04 Chong Kun Dang Corp
JP4094710B2 (en) 1997-11-06 2008-06-04 株式会社ヤクルト本社 New camptothecin derivatives
AU775373B2 (en) 1999-10-01 2004-07-29 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
FR2801309B1 (en) * 1999-11-18 2002-01-04 Adir NOVEL CAMPTOTHECIN-LIKE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
JP4305909B2 (en) * 2001-11-30 2009-07-29 中外製薬株式会社 Hexacyclic compounds
US7563810B2 (en) 2002-11-06 2009-07-21 Celgene Corporation Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases
US8034831B2 (en) 2002-11-06 2011-10-11 Celgene Corporation Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-Dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies
EP1599484A2 (en) 2003-02-21 2005-11-30 Chugai Seiyaku Kabushiki Kaisha Process for the preparation of hexacyclic camptothecin derivatives
BRPI0509732A (en) 2004-04-09 2007-09-25 Chugai Pharmaceutical Co Ltd water soluble prodrug, pharmaceutical composition, therapeutic agent, antifungal agent and use of said prodrug
TW200744603A (en) 2005-08-22 2007-12-16 Chugai Pharmaceutical Co Ltd Novel anticancer concomitant drug
CN102060713A (en) * 2010-12-09 2011-05-18 中华人民共和国嘉兴出入境检验检疫局 Aromatic amine hapten for detecting azo dyes and preparation method thereof
CN118240003A (en) 2019-03-29 2024-06-25 免疫医疗有限公司 Compounds and conjugates thereof
BR112022014391A2 (en) 2020-01-22 2022-09-13 Medimmune Ltd COMPOUNDS AND CONJUGATIONS THEREOF
TW202140076A (en) 2020-01-22 2021-11-01 英商梅迪繆思有限公司 Compounds and conjugates thereof
US11806405B1 (en) 2021-07-19 2023-11-07 Zeno Management, Inc. Immunoconjugates and methods
WO2023180490A1 (en) 2022-03-23 2023-09-28 Synaffix B.V. Antibody-conjugates for targeting of tumours expressing nectin-4
WO2023180485A1 (en) 2022-03-23 2023-09-28 Synaffix B.V. Antibody-conjugates for targeting of tumours expressing trop-2
WO2023180484A1 (en) 2022-03-23 2023-09-28 Synaffix B.V. Antibody-conjugates for targeting of tumours expressing ptk7
WO2023180489A1 (en) 2022-03-23 2023-09-28 Synaffix B.V. Antibody-conjugates for targeting of tumours expressing carcinoembyronic antigen

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0056692A1 (en) * 1981-01-09 1982-07-28 Kabushiki Kaisha Yakult Honsha 7-Substituted camptothecin derivatives and process for their preparation
EP0074256A1 (en) * 1981-09-04 1983-03-16 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives, processes for preparing same, formulations containing such derivatives and their use
EP0088642A2 (en) * 1982-03-10 1983-09-14 Kabushiki Kaisha Yakult Honsha New camptothecin derivatives and process for their preparation
EP0137145A1 (en) * 1983-07-14 1985-04-17 Kabushiki Kaisha Yakult Honsha New camptothecin derivatives and process for preparing same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US32518A (en) * 1861-06-11 Improvement in city railroads
JPS51288A (en) * 1974-06-18 1976-01-05 Tamura Seisakusho Kk HANSHAKYOSHI NHOSHASOCHI
US4399282A (en) * 1979-07-10 1983-08-16 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives
JPS5839685A (en) * 1981-09-04 1983-03-08 Yakult Honsha Co Ltd Novel camptothecin derivative and its preparation
EP0220601B1 (en) * 1985-10-21 1991-12-11 Daiichi Seiyaku Co., Ltd. Pyranoindolizine derivatives and preparation process thereof
US4939255A (en) * 1987-06-24 1990-07-03 Daiichi Pharmaceutical Co., Ltd. Hexa-cyclic camptothecin derivatives
US5004758A (en) * 1987-12-01 1991-04-02 Smithkline Beecham Corporation Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells
JPH0615547B2 (en) * 1988-01-20 1994-03-02 株式会社ヤクルト本社 Novel camptothecin derivative

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0056692A1 (en) * 1981-01-09 1982-07-28 Kabushiki Kaisha Yakult Honsha 7-Substituted camptothecin derivatives and process for their preparation
EP0074256A1 (en) * 1981-09-04 1983-03-16 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives, processes for preparing same, formulations containing such derivatives and their use
EP0088642A2 (en) * 1982-03-10 1983-09-14 Kabushiki Kaisha Yakult Honsha New camptothecin derivatives and process for their preparation
EP0137145A1 (en) * 1983-07-14 1985-04-17 Kabushiki Kaisha Yakult Honsha New camptothecin derivatives and process for preparing same

Also Published As

Publication number Publication date
DE3851577T2 (en) 1995-04-27
US5061795A (en) 1991-10-29
AU1834988A (en) 1989-01-05
IE61281B1 (en) 1994-10-19
DE3851577D1 (en) 1994-10-27
FI91872B (en) 1994-05-13
IE881860L (en) 1988-12-24
ATE111913T1 (en) 1994-10-15
DK344488D0 (en) 1988-06-23
ES2064329T3 (en) 1995-02-01
NO167738B (en) 1991-08-26
US4939255A (en) 1990-07-03
PH27557A (en) 1993-08-18
KR890000489A (en) 1989-03-15
NO882785D0 (en) 1988-06-23
EP0296597A2 (en) 1988-12-28
CA1304370C (en) 1992-06-30
AU610189B2 (en) 1991-05-16
NO167738C (en) 1991-12-04
NO882785L (en) 1988-12-27
FI883050A0 (en) 1988-06-23
EP0296597B1 (en) 1994-09-21
DK344488A (en) 1989-02-24
FI883050A (en) 1988-12-25
FI91872C (en) 1994-08-25
KR960002853B1 (en) 1996-02-27

Similar Documents

Publication Publication Date Title
EP0296597A3 (en) Hexa-cyclic compound
CA2059305A1 (en) Hexa-cyclic compound
EP0386683A3 (en) Xanthine derivatives having bronchodilating activity, a process for the preparation thereof and pharmaceutical compositions containing them
EP0369262A3 (en) Novel pyrroles
AU577928B2 (en) Labd-14-en-11-one derivatives
EP0327709A3 (en) Novel platinum complex, antineoplastic agent containing the same, intermediate therefor, preparation method and use
EP0264744A3 (en) Process for the preparation of 4,4'-diaminodiphenylmethane and its derivatives.
EP0342989A3 (en) Polymaleimide compounds and process for the preparation thereof
EP0193164A3 (en) Sustained-release pharmaceutical preparation which comprised 2-nitroxy-methyl-6-chloropyridine, process for its preparation and use thereof
ZA898921B (en) 2-azabicyclo(2.2.1)herp-5-ene-2-acetic acid,derivatives thereof and related compounds,process for the preparation of said compounds and the use of said compounds for the manufacture of n-phosphonomethylglycine
AU8182187A (en) Medicaments based on derivatives of 3,4-diphenylpiperidine the use of the derivatives as medicaments, and novel 3,4- diphenylpiperidine derivatives and a process for the preparation thereof
EP0270682A4 (en) Novel complexes, process for their preparation, and medicinal use of them.
EP0194563A3 (en) Glycosides and process for preparation thereof
JPS6470470A (en) Novel 1,2-diamino compound, manufacture and drug
EP0295783A3 (en) A derivative of codeine
EP0317882A3 (en) Fluor containing compounds based on 4,4-bisû2-(4-hydroxy-phenyl)hexafluorisopropyl¨diphenylether, process for their preparation and use
AU5958690A (en) 2-amino-7-carbamoyl-1,2,3,4-tetrahydronaphthalenes, process for preparing them and their use as drugs
AU1065488A (en) 3-Methylenespiro(Benzofuranpiperidines), intermediates and process for the preparation thereof, and their use as medicaments
EP0294921A3 (en) Thiapyrylium dyes useful as anti-cancer agents
EP0184133A3 (en) The use of polyamidoamines as hardening catalysts for epoxy resins
ZA876225B (en) Process for the preparation of n,n'-tetrathiodimorpholine
Fewer The process of preparing psychologically for fatherhood
EP0381138A3 (en) Antitumor substance be-12406
EP0345711A3 (en) Process for the preparation of pyrrolizine derivatives
AU8045587A (en) Process for the preparation of n-acyl-n-alkyl-2,6-dialkyl-3- chloroanilines

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH DE ES FR GB GR IT LI NL SE

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE CH DE ES FR GB GR IT LI NL SE

17P Request for examination filed

Effective date: 19911030

17Q First examination report despatched

Effective date: 19921204

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: KABUSHIKI KAISHA YAKULT HONSHA

Owner name: DAIICHI PHARMACEUTICAL CO., LTD.

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH DE ES FR GB GR IT LI NL SE

REF Corresponds to:

Ref document number: 111913

Country of ref document: AT

Date of ref document: 19941015

Kind code of ref document: T

REF Corresponds to:

Ref document number: 3851577

Country of ref document: DE

Date of ref document: 19941027

ET Fr: translation filed
ITF It: translation for a ep patent filed

Owner name: SOCIETA' ITALIANA BREVETTI S.P.A.

REG Reference to a national code

Ref country code: GR

Ref legal event code: FG4A

Free format text: 3013350

EAL Se: european patent in force in sweden

Ref document number: 88110044.0

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2064329

Country of ref document: ES

Kind code of ref document: T3

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 19970526

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GR

Payment date: 19970530

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 19970609

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 19970610

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 19970617

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: AT

Payment date: 19970620

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 19970625

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 19970627

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 19970630

Year of fee payment: 10

Ref country code: ES

Payment date: 19970630

Year of fee payment: 10

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19980623

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19980623

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19980624

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19980624

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19980630

Ref country code: GR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19980630

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19980630

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19980630

BERE Be: lapsed

Owner name: YAKULT HONSHA K.K.

Effective date: 19980630

Owner name: DAIICHI PHARMACEUTICAL CO. LTD

Effective date: 19980630

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19990101

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 19980623

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19990226

EUG Se: european patent has lapsed

Ref document number: 88110044.0

NLV4 Nl: lapsed or anulled due to non-payment of the annual fee

Effective date: 19990101

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19990401

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20000403

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED.

Effective date: 20050623